Expanding Diversity in Family Building Through IVF Advances

Recent IVF data from Australia and New Zealand highlight increased inclusivity and technological advancements, enabling diverse family structures through safer and more effective reproductive options.
In 2023, the use of In Vitro Fertilization (IVF) in Australia and New Zealand demonstrated a significant shift towards more inclusive family structures. Data from the Australian and New Zealand Assisted Reproduction Database (ANZARD) reveal that one in five IVF cycles were undertaken by single women or female same-sex couples, reflecting a broader understanding of infertility as a condition not limited to heterosexual couples.
The report indicates that a total of 20,417 babies were born via IVF in that year, maintaining a similar figure to the previous year. This accounts for about 1 in every 16 births in Australia and 1 in 27 in New Zealand, with a growing number of cycles performed—over 109,000—marking a 3.6% increase from 2022.
Particularly notable is the rise in IVF use among single women, with their cycles increasing from nearly 9,500 in 2020 to over 15,900 in 2023. Female same-sex couples also saw growth from 3,648 cycles in 2020 to 4,777 in 2023. Experts highlight that the evolving definition of infertility now more inclusively includes individuals facing barriers to biological parenthood based on their relationship status or sexual orientation.
Donor sperm, eggs, and surrogacy arrangements have become key components in facilitating family creation for those without partners or in same-sex partnerships. In 2023, around 60 cycles involved egg or embryo donation aimed at single men or male same-sex couples, with more than 100 births resulting from surrogacy arrangements.
Technological advances continue to shape the field. Fertility preservation techniques, such as egg and embryo freezing, have surged, especially among women choosing to safeguard their future fertility. Nearly 9,000 preservation cycles were conducted in 2023, including a rise in egg freezing for non-medical reasons. Additionally, nearly 10,000 cycles employed preimplantation genetic testing (PGT) to enhance embryo selection, with success rates improving notably among women in their early 30s.
Safety measures have also advanced. Australia and New Zealand lead globally in reducing health risks associated with multiple pregnancies by promoting single embryo transfers, resulting in record low multiple birth rates of 2.2%. Success rates of IVF have improved, with nearly 40% of women achieving pregnancy in their first cycle between 2020 and 2021. Use of frozen embryos, now at 40% of cycles, has contributed to higher success outcomes.
Overall, the trends in IVF in these countries point towards more effective, safe, and inclusive reproductive options, catering to a diverse population seeking family-building solutions.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative Rapid Test Aims to Save Lives from Deadly Fungal Infection on the Rise During Pandemic
A new rapid lateral-flow test developed by researchers aims to diagnose deadly mucormycosis infections quickly, especially critical during the pandemic's surge in cases, potentially saving lives through early detection.
No Driving Impairment in Frequent Cannabis Users After Two-Day Abstinence
New research from UC San Diego reveals that frequent cannabis users show no driving impairment after abstaining for at least two days, challenging traditional notions about cannabis and impairment risk.
Advanced Machine Learning Enhances 3D Imaging for Fetal Health Assessment
Innovative machine learning techniques are now enabling detailed 3D modeling of fetal health, improving measurement accuracy and diagnostics through advanced MRI analysis.
Innovative Gene Therapy Protects Hearing and Balance in Preclinical Studies
A groundbreaking gene therapy from Tel Aviv University effectively preserves hearing and balance in preclinical models, promising new treatments for genetic ear disorders.